LAC Med Berhad (KLSE:LACMED)
0.7000
-0.0150 (-2.10%)
At close: Jun 9, 2026
LAC Med Berhad Balance Sheet
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 24.39 | 30.55 | 15.84 | 30.45 | 23.83 |
Short-Term Investments | 46.44 | 52.49 | 27.74 | 2.94 | 0.95 |
Cash & Short-Term Investments | 70.83 | 83.04 | 43.58 | 33.39 | 24.77 |
Cash Growth | 62.51% | 90.52% | 30.51% | 34.80% | - |
Accounts Receivable | 87.19 | 80.14 | 38.74 | 68.73 | 50.96 |
Other Receivables | 10.81 | 1.13 | 0.42 | 0.38 | 0.29 |
Receivables | 98 | 81.27 | 39.16 | 69.11 | 51.24 |
Inventory | 29.17 | 27.78 | 20.8 | 21.61 | 10.84 |
Prepaid Expenses | - | 0.67 | 0.42 | 0.13 | 0.08 |
Other Current Assets | - | 7.79 | 20.02 | 11.88 | 14.08 |
Total Current Assets | 197.99 | 200.54 | 123.99 | 136.12 | 101.02 |
Property, Plant & Equipment | 12.45 | 9.81 | 1.46 | 1.36 | 0.6 |
Other Intangible Assets | 2.69 | 2.83 | - | - | - |
Long-Term Deferred Tax Assets | 2.04 | 2.04 | 2.66 | 2.13 | 1.63 |
Total Assets | 215.18 | 215.23 | 128.11 | 139.61 | 103.25 |
Accounts Payable | 39.83 | 38.6 | 28.74 | 37.53 | 19.28 |
Accrued Expenses | - | 5.34 | 3.62 | 4.16 | 1.42 |
Short-Term Debt | - | 20.93 | 18.15 | 22.43 | 31.25 |
Current Portion of Long-Term Debt | 24.79 | 0.17 | 0.77 | 0.82 | 0.77 |
Current Portion of Leases | 1.12 | 0.17 | 0.11 | 0.15 | 0.12 |
Current Income Taxes Payable | -0.04 | 2.91 | 2.1 | 1.84 | 1.99 |
Current Unearned Revenue | 7.61 | 7.47 | 13.96 | 16.36 | 12.22 |
Other Current Liabilities | 17.21 | 19.55 | 11.36 | 14.2 | 7.98 |
Total Current Liabilities | 90.52 | 95.15 | 78.81 | 97.47 | 75.02 |
Long-Term Debt | 1.02 | 1.07 | 1.3 | 2.06 | 2.88 |
Long-Term Leases | 3.69 | 0.11 | 0.1 | 0.21 | 0.23 |
Total Liabilities | 95.28 | 96.32 | 80.21 | 99.75 | 78.13 |
Common Stock | 102.2 | 102.2 | 2 | 2 | 2 |
Retained Earnings | 63.78 | 62.75 | 45.77 | 37.87 | 23.12 |
Comprehensive Income & Other | -46.12 | -46.11 | -0 | - | - |
Total Common Equity | 119.86 | 118.84 | 47.76 | 39.87 | 25.12 |
Minority Interest | 0.04 | 0.06 | 0.14 | - | - |
Shareholders' Equity | 119.9 | 118.91 | 47.9 | 39.87 | 25.12 |
Total Liabilities & Equity | 215.18 | 215.23 | 128.11 | 139.61 | 103.25 |
Total Debt | 30.62 | 22.45 | 20.42 | 25.67 | 35.24 |
Net Cash (Debt) | 40.21 | 60.58 | 23.16 | 7.72 | -10.47 |
Net Cash Growth | 73.59% | 161.57% | 199.90% | - | - |
Net Cash Per Share | 0.19 | 0.52 | 11.58 | 3.86 | -5.23 |
Filing Date Shares Outstanding | 400 | 400 | 2 | 2 | 2 |
Total Common Shares Outstanding | 400 | 400 | 2 | 2 | 2 |
Working Capital | 107.48 | 105.4 | 45.17 | 38.65 | 26 |
Book Value Per Share | 0.30 | 0.30 | 23.88 | 19.93 | 12.56 |
Tangible Book Value | 117.17 | 116.01 | 47.76 | 39.87 | 25.12 |
Tangible Book Value Per Share | 0.29 | 0.29 | 23.88 | 19.93 | 12.56 |
Machinery | - | 11.15 | 2.05 | 1.67 | 1.17 |
Order Backlog | - | 216.7 | - | - | - |